Gb Sciences, Inc. · OTC:GBLX
Gb Sciences — Investor Presentation (March 2018)
19 slides from Gb Sciences's investor presentation, Mar 12, 2018
Slide 1: gbsciences: the future of healing
gbsciences the future of healing This document may contain statements relating to future results or events, which are forward-looking statements. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forwar
Slide 2: Cannabis Investment Quiz
Cannabis Investment Quiz What do you call a company that... Quietly builds an innovative and responsible cannabis company for the long game? Trades at % the value of similar sized companies based purely on cannabis revenue? Has patented and patentable IP in both Life Sciences and Genetics that is no
Slide 3: How to Spot an Elephant in the Middle of the Room
How to Spot an Elephant in the Middle of the Room GB Sciences Cultivation Comparables (Selection) In SUS millions GB Sciences $92 $5.1 @ £00k for the value players that the market hasn't yet realized have hidden assets. Elephant e Stick with them. They're the ones that'll still be . _ standing when
Slide 4: Three business focuses: cannabis products, life sciences, genetics
that you've ‘spotted the elephant, let's get a little closer in. x wy Cannabis aoa . Sy Products Cash flow from cultivation and extraction GBS isa diverse, ’ science-based Life Patented and patentable IP for cannabis-based cannabis company Sciences medical formulations with three business focuses Br
Slide 5: Cannabis Products: Solving the Jumbo Sized Riddles
Cannabis Products: Solving the Jumbo Sized Riddles The jumbo sized riddle has been the inability to produce consistent raw materials for plant based medical formulations. Until now. Two things control producing consistent plants - the genetics and the growing environment. Tissue culture propagation
Slide 6: Cannabis Products: Our Facility in Las Vegas
Cannabis Products: Our Facility in Las Vegas Elephantidae Hipstericus The trunk that feeds the beast with recurring monthly revenue. And that’s not peanuts. Precision controlled growing environments enable us to produce a plant that is consistent and beneficial on two levels. = ’ Level 1: Biopharma;
Slide 7: Cannabis Products: Extraction & Production
Cannabis Products: Extraction & Production The tried and true routines sell tickets and keep ‘em coming back for more. High volume ethanol extraction targeting up to 500,000 grams per month C02 extraction for medical formulations
Slide 8: Cannabis Products: Keeping It in the Family
Cannabis Products: Our e Keeping It In the Family Egtta Creating and Licensing Brands: The best way to build a big, beautiful, extended family. , CURA CANNABIS SOLUTIONS artners perating under *, GB licenses with ‘)
Slide 9: Cannabis Products: Expanding Our Range
Size, strength and adaptability allow our extended Canna bis Prod uct e fem of Dest ices bar triere to easky move into Expanding Our Range [haiemastennemanasa
Slide 10: Anticipated performance figures
Anticipated performance figures. Alll figures in USD millions unless otherwise specified. Copal Need = ae $620 $10 $14 isingfectty Proketon | S36Lights $620 $6 $5 $23 $24 $u7 Sandy Valley Cultivation Gicpes,, $620 $3 $4 $10 $10 $29 AcquisitionX Foci © 716 Lights $620 $13 $16 $48 $49 $196 RR e $5B $5
Slide 11: Expansion: Louisiana, California, Nevada
a ee ee ee ee ee LOUISIANA EXPANSION CALIFORNIA EXPANSION ? NEVADA EXPANSION fr EXISTING NEVADA FACILITY
Slide 12: Margins & Metrics
Margins & Metrics KeEzaiurs Average Sales Price $3.99/g : Adjusted COGS $1.08/g)—_ Gross Margin 73% $3.99 -$1.08 de
Slide 13: Life Sciences: One of Our Ivory Tusks
Life Sciences: _ One of Our Ivory Tusks Patents covering multiple conditions 7 Hypertension, Cardiac Hypertrophy Parkinson’s Disease, Alzheimer’s Disease, Dementia, Huntington's Disease Chronic Pain, Immunological Pain, Neuropathic Pain Eczema, Psoriasis & Dermatitis, Rheumatoid Arthritis & Osteoart
Slide 14: Life Sciences: Thinking Outside the Box
We are much bigger than the box, so it’s easy for us to think outside it. Now that's organic value creation. Accelerated Monetization of Research Through Innovative Thought And Action Novel FDA Strategy-quicker to First-in-Man Using an Exploratory IND & Phase 0 Human Trial © Multiple formulations ta
Slide 15: Scientific partners and research collaborators
C ) Innovative, well-informed, dedicated to Ite and cooperation J ary * r Our approach to science has ea scientific partners, researchers al e in Health ity of Hay e fersity of Ca
Slide 16: Genetics: Herd Mentality
Genetics: Herd Mentality The Louisiana State University Agricultural Center is an industry leader in developing proprietary genetics for the agricultural industry. Together, our team of partners can work towards meeting the medical needs of patients. Through scientific based research and technology
Slide 17: Elephant Think: Our Corporate Culture
Elephant Think: Our Corporate Culture Every single team ote from the front desk to the C-Suite is smart, committed, and wholly dedicated to maintaining what we like to call ‘the vibe’. This is our corporate culture. y a » Something that we never forget. & = We consider all consumers to be patients.
Slide 18: Seasoned Management Team
John Poss Chairman and CEO ‘With over 30 years of experience, CEO&Chairman John Poss is still thinking outside of the box. He brings expertise in working as a consultant to companies facing major transformations and transitions, and as an executive piloting large and successful companies. Seasoned M
Slide 19: Slide 19